NCT05273775View on ClinicalTrials.gov

A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 29, 2022

Primary Completion Date

June 23, 2022

Study Completion Date

June 23, 2022

Conditions
Chronic Hepatitis B
Interventions
DRUG

HRS5091 Tablets

HRS5091 Tablets once daily

DRUG

Midazolam Maleate Tablets

Midazolam Maleate Tablets single dose

DRUG

Warfarin Sodium Tablets

Warfarin Sodium Tablets single dose

DRUG

Omeprazole Enteric Capsules

Omeprazole Enteric Capsules single dose

DRUG

Vitamin K1 Tablets

Vitamin K1 Tablets once daily

DRUG

Digoxin Tablets

Digoxin Tablets single dose

DRUG

Rosuvastatin Calcium Tablets

Rosuvastatin Calcium Tablets single dose

Trial Locations (1)

510260

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY